Comparison of two dosing regimens of gabexate mesilate (FOY® in the prevention of post-ercp pancreatitis: Results of a multicentre controlled trial
A. Mariani, L. Frulloni, E. Masci, S. Curioni, A. Tittobello, G. CavalliniVolume:
33
Year:
2001
Language:
english
DOI:
10.1016/s1590-8658(01)80299-1
File:
PDF, 153 KB
english, 2001